PUBLISHED: 06:26, Thu, Dec 3, 2020 | UPDATED: 06:32, Thu, Dec 3, 2020
It comes after the UK becomes the first western country to approve the use of that particular vaccine, developed by US pharmaceutical company Pfizer and German biotechnology firm BioNTech. The Department of Health and Social Care said the vaccine could begin being delivered round the country by next week.
Trials have shown the jab offers up to 95 percent protection against Covid-19 symptoms.
Last night, Sean Marett, Chief Commercial Officer of BioNTech, warned “we cannot say yet” whether its vaccine stops someone from spreading Covid-19.
Speaking on BBC Newsnight, Mr Marett said: “What we can answer is the question: What sort of protection do we see?Insurance Loans Mortgage Attorney Credit Lawyer
The Government announced a vaccine approval on Tuesday (Image: Andy Buchanan / AFP / Getty)
“Protection is defined as, in our clinical trial of 43,000 folks: Do you get symptoms of Covid or not, on our vaccine versus a placebo arm?
“And the answer is in 95 percent of cases, you do not, on this vaccine, get symptoms of the virus.
“And that’s true for all age groups – elderly, over 65s, through down to 18-year-olds.
READ: Disaster for Donald Trump as US faces ‘toughest three months in history’ from coronavirus
BioNTech's Sean Marett, speaking on BBC Newsnight (Image: Twitter / BBC / @BBCNewsnight)
“Now, does that mean that we don’t spread it? That’s for further scientific analysis. We cannot say yet.”
Pfizer has confirmed that the first doses of the vaccine are on their way to the UK, with 800,000 due in coming days.
It will be delivered via the NHS only – meaning it will not be available for people to jump the